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ABSTRACT Tiam1 is one of the most extensively analyzed activators of the small GTPase Rac. 
However, fundamental aspects of its regulation are poorly understood. Here we demonstrate 
that Tiam1 is functionally suppressed by internal interactions and that the PAR complex par-
ticipates in its full activation. The N-terminal region of Tiam1 binds to the protein-binding and 
catalytic domains to inhibit its localization and activation. Atypical PKCs phosphorylate Tiam1 
to relieve its intramolecular interactions, and the subsequent stabilization of its interaction 
with PAR3 allows it to exert localized activity. By analyzing Tiam1 regulation by PAR3-aPKC 
within the context of PDGF signaling, we also show that PAR3 directly binds PDGF receptor 
β. Thus we provide the first evidence for the negative regulation of Tiam1 by internal interac-
tions, elucidate the nature of Tiam1 regulation by the PAR complex, and reveal a novel role 
for the PAR complex in PDGF signaling.
INTRODUCTION
T-cell lymphoma invasion and metastasis 1 (Tiam1) was first identi-
fied as a proinvasion factor in T-lymphocytes (Habets et al., 1994) 
and is now widely recognized as a critical regulator of various cellu-
lar functions during development and disease in multiple cell types 
(reviewed in Mertens et al., 2003; Cook et al., 2014). A typical mem-
ber of the Dbl family of guanine nucleotide exchange factors (GEFs), 
that is, activators for the Rho small GTPases, its functional core is a 
carboxyl (C)-terminal tandem Dbl homology/pleckstrin homology 
(DHPH) domain. It exhibits exchange activity only for Rac1 in vivo 
(Michiels et al., 1995). Protein–protein interactions play an important 
role in localizing Tiam1 to specific membrane subdomains (Bourgui-
gnon et al., 2000; Nishimura et al., 2005; Tolias et al., 2005, 2007; 
Miyamoto et al., 2006). These interactions are primarily mediated 
through a modified PH domain near the amino (N)-terminal region, 
the coiled-coil/extended region (PHnCCEx) domain (Stam et al., 
1997; Terawaki et al., 2010).
One of the most extensively characterized interactions is the di-
rect binding of Tiam1 with partitioning defective 3 (PAR3), through 
which Tiam1 forms a complex with other PAR polarity proteins, 
namely PAR6 and atypical protein kinase C (aPKC; PAR complex; 
Nishimura et al., 2005). The PAR complex is a crucial, intrinsic de-
terminant of cell polarity (Suzuki and Ohno, 2006). The functional 
interaction between Tiam1 and PAR3 is required for many cell po-
larization events, including axon specification (Nishimura et al. 
2005), dendritic spine morphogenesis (Zhang and Macara, 2006), 
and synaptogenesis (Duman et al., 2013) in neurons, as well as for 
both chemotactic (Pegtel et al., 2007) and haptotactic (Wang et al., 
2012) directional cell migration. The interaction of Tiam1 with PAR3 
serves to spatially restrict Rac1 activation and localize cytoskeletal 
remodeling (reviewed in Iden and Collard, 2008). An additional 
functional interaction with the PAR complex exists through aPKC, 
as aPKC activity is required for proper signaling through Tiam1 dur-
ing polarized migration (Pegtel et al., 2007; Wang et al., 2012). 
Moreover, Tiam1 is an aPKC substrate in vitro, with the phosphory-
lation site(s) residing within the N-terminal inhibitory region (Wang 
et al., 2012).
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aPKC-phosphorylation sites is highly conserved across species and 
enriched in basic amino acids (Supplemental Figure S1A). Further-
more, this region is generally considered to be inhibitory, although 
no mechanistic basis for this assertion has been reported (Michiels 
et al., 1997; reviewed in Mertens et al., 2003). These observations 
suggested that the N-terminal region of Tiam1 might mediate intra-
molecular interaction(s), and its phosphorylation might regulate 
these interactions by altering the electrochemical properties of this 
region. Therefore we performed an in vitro binding assay to investi-
gate this possibility; we passed maltose-binding protein (MBP)–
fused C-terminal Tiam1 fragments (–PHnCCEx, –RBD/PDZ, and –
DHPHc; Figure 1A) through columns of glutathione S-transferase 
(GST)–Tiam1-N392. The adjacent PHnCCEx domain and, to a lesser 
extent, the most C-terminal DHPHc region were efficiently pulled 
down (Figure 2A). A similar binding pattern was observed for Tiam2/
STEF (Supplemental Figure S1C). When we analyzed the mode of 
PHnCCEx binding to the N-terminal region of Tiam1, we found that 
the intact PHnCCEx fragment was necessary for an efficient interac-
tion (Figure 2B). This result is consistent with a previous structural 
report that showed that the PHn, CC, and Ex subdomains folded 
into a single globular domain (Terawaki et al., 2010). In contrast, the 
DH domain of DHPHc did not contribute significantly to the interac-
tion with the N-terminal region of Tiam1 (Figure 2B). We also char-
acterized the segment of the N-terminal region of Tiam1 that was 
required for PHnCCEx and DHPHc binding and found that Tiam1-
N50, which was the minimum fragment that was phosphorylated by 
aPKC, was solely responsible for these interactions (Figure 2C). 
Given this observation, we next investigated whether the aPKC-
mediated phosphorylation of the N-terminal region could modulate 
its interaction with PHnCCEx. Indeed, PHnCCEx binding was se-
verely diminished when Tiam1-N392 was preincubated with aPKC in 
the presence of ATP. These results indicate that reversible internal 
interactions mediated by phosphorylation are important factors in 
Tiam1 regulation (Figure 2E).
Functional significance of Tiam1 intramolecular interactions
The two regions to which the N-terminal region of Tiam1 binds 
have critical functions: PHnCCEx functions as a protein–protein in-
teraction domain, and the C-terminal PH functions as a regulator of 
catalytic activity through its interaction with lipid messengers 
(Baumeister et al., 2003; Viaud et al., 2014). Therefore we investi-
gated the effects of the intramolecular interactions on these func-
tions. When Tiam1 was immunoprecipitated from lysates of NIH-
3T3 cells expressing the constitutively active mutant of the two 
aPKC isoforms, PAR3 coprecipitation was significantly increased 
compared with the vector control; PAR3 coprecipitation under the 
WT and KN aPKC conditions was not significantly different from 
that of the vector control (Figure 3, A and B). To validate that this 
effect was specifically dependent on Tiam1 phosphorylation by 
aPKC, we performed an in vitro competition assay based on the 
experiments described in Figure 2. The Tiam1-binding region of 
PAR3, PAR3-4N (Supplemental Figure S5A), efficiently pulled down 
Tiam1-PHnCCEx, either alone or in the presence of the control 
competitor protein MBP (Figure 3, C and D). However, when MBP-
Tiam1-N/1-WT was introduced as the competitive element, the 
PHnCCEx pull-down efficiency was significantly reduced. Of impor-
tance, the addition of the phosphomimetic N-terminal fragment 
abolished this titration effect, demonstrating that aPKC phosphory-
lation of Tiam1 regulates its protein–protein interactions through 
the PHnCCEx domain (Figure 3, C and D).
We next examined the potential regulation of Tiam1 GEF activ-
ity by the N-terminal region of Tiam1. Several previous reports 
These observations suggest a crucial role for Tiam1 phosphory-
lation by aPKC. Because many of the basic aspects of Tiam1 regula-
tion remain poorly understood, we performed a detailed analysis 
regarding the function of Tiam1 phosphorylation by aPKC. We show 
that Tiam1 is regulated by internal interactions in a signal-sensitive 
manner that is dependent on its phosphorylation by aPKC. Inciden-
tal to this demonstration, our work also expands the role of the PAR 
complex in receptor tyrosine kinase (RTK) signaling by identifying 
PAR3 as a novel interacting partner for platelet-derived growth fac-
tor (PDGF) receptor β (PDGFRβ) and by revealing its role in mediat-
ing PDGF signaling to Rac1 through Tiam1.
RESULTS
Phosphorylation of Tiam1 by aPKC
We previously identified Tiam1 as a novel substrate of aPKC in vitro 
and mapped the phosphorylation site(s) to the N-terminal region 
(Tiam1-N392; Wang et al., 2012). As an initial step toward identify-
ing potential phosphorylation site(s), we performed in vitro phos-
phorylation assays on the N-terminal Tiam1 fragments Tiam1-N/1 
(amino acids [aa] 1–130), Tiam1-N/2 (aa 131–260) and Tiam1-N/3 
(aa 261–392) using the catalytic domain of aPKCλ (aPKCλ-cat). 
Tiam1-N/1 was phosphorylated at least as efficiently as the full-
length N-terminal fragment, whereas neither Tiam1-N/2 nor Tiam1-
N/3 was phosphorylated (Figure 1, A and B). We also found that the 
N-terminal-most 50 amino acids (–N50) were phosphorylated with a 
stoichiometry similar to that of the longer fragments (unpublished 
data). On the basis of these results, we next determined the specific 
residues that were phosphorylated by examining the in vitro phos-
phorylation of Tiam1-N/1, in which the serine and threonine resi-
dues of the consensus PKC phosphorylation motifs ([S/T]-X-[R/K], 
[R/K]-X-[S/T], and [R/K]-X-X-[S/T]) within the most N-terminal 50 aa 
were mutated to alanine. The Ser-29 (A29) and Ser-33 (A33) muta-
tions resulted in significant reductions in phosphorylation, to as 
much as 40% that of the wild-type (WT) fragment when both resi-
dues were simultaneously mutated, suggesting that these two ser-
ine residues are primarily phosphorylated by aPKC in vitro (Figure 
1C). Tiam2/STEF is a Tiam1 homologue, with a similar overall do-
main architecture (Chiu et al., 1999). We found that the analogous 
N-terminal region of Tiam2/STEF (N463) was also phosphorylated 
by aPKC in vitro (Supplemental Figure S1B).
To analyze the significance of these phosphorylation sites, we 
produced antibodies based on phosphorylation at the respective 
residues and successfully characterized an anti–phospho-Ser-29 
(Tiam1-pS29) antibody (Figure 1, D and E). When this antibody was 
used in an immunoblot analysis of recombinant N-terminal Tiam1 
incubated with aPKCλ-cat in either the absence or presence of ATP, 
anti-Tiam1-pS29 antibody immunoreactivity was dose dependent 
and restricted to the proteins that were incubated in the presence of 
ATP (Figure 1D). Immunoblot analysis of COS-7 cell lysates contain-
ing full-length (FL) Tiam1 (Tiam1-FL–hemagglutinin [HA]) and aPKCλ 
(myc-aPKCλ) demonstrated that coexpression of aPKCλ-WT en-
hanced the immunoreactivity of the anti-Tiam1-pS29 antibody, 
whereas coexpression of kinase-negative (KN) aPKCλ (aPKCλ-KN) 
reduced this immunoreactivity. Of importance, Tiam1-A29 was not 
detected even when aPKCλ-WT was coexpressed, suggesting that 
this antibody is specific for phosphorylation at Ser-29 (Figure 1E).
aPKC phosphorylation regulates Tiam1 interdomain binding
Many modular signaling proteins, including several RhoGEFs, are 
regulated by interactions among their domains (reviewed in Ross-
man et al., 2005). The Tiam1 N-terminal region contains no func-
tional domains; however, the region immediately surrounding the 
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was suppressed by treatment of NIH-3T3 cells with an inhibitor of 
the phosphatidylinositol phosphate kinase, PIKfyve, which inhibits 
the formation of phosphatidylinositol 3,5-bisphosphate and Pt-
dIns5P (Jefferies et al., 2008). The inhibitor treatment significantly 
decreased Akt-S473 phosphorylation, which requires the presence 
showed that the binding of phospholipids, namely phosphatidylino-
sitol 5-phosphate (PtdIns5P), to PHc can up-regulate Tiam1 GEF 
activity (Baumeister et al., 2003; Viaud et al., 2014). Thus we at-
tempted to analyze the role of aPKC phosphorylation within this 
framework. The de novo synthesis of 5-phosphate phospholipids 
FIGURE 1: Tiam1 is phosphorylated by aPKC at serine residue 29 in vitro and in cells. (A) Schematic overview of Tiam1. 
The domain organization and the fragments used. The N-terminal PH domain together with the CC and Ex regions 
constitute a functional domain. Representative protein interactors. (B) The N-terminal-most 130 amino acids of Tiam1 are 
phosphorylated by aPKC in vitro. The GST-fused N-terminal Tiam1 fragments (indicated by asterisks in the silver-stained 
gel image) were incubated with GST-aPKCλ-cat in the presence of [γ-32P]ATP, and phosphorylation was determined by 
autoradiography. The arrow indicates GST-aPKCλ-cat. (C) Ser-29 and Ser-33 of Tiam1 are specifically phosphorylated by 
aPKC in vitro. GST-Tiam1-N/1 (1–130) harboring alanine mutations of the serine and threonine residues within the 
N-terminal-most 50 amino acids were prepared, and an in vitro phosphorylation assay was performed as described in B. 
(D, E) The immunoreactivity of the phosphorylated anti-Tiam1 antibody (anti-Tiam1-pS29) is phosphorylation-site specific. 
The antibody was purified from a rabbit inoculated with a Tiam1 peptide phosphorylated at serine 29. (D) The anti-
Tiam1-pS29 antibody specifically recognizes the in vitro–phosphorylated Tiam1 N-terminal fragment. GST-Tiam1-N392 
(1–392) was incubated with GST-aPKCλ-cat in the presence or absence of [γ-32P]ATP and immunoblotted with anti-Tiam1-
pS29 antibody. (E) aPKCλ coexpression with Tiam1 induces an increase in Tiam1-pS29 immunoreactivity. COS-7 cells 
were transfected with Tiam1-HA and the indicated myc-aPKC constructs, and the lysates were immunoblotted with the 
indicated antibodies. Experiments shown are representative of at least three independent experiments.
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presence of a PIKfyve inhibitor. The cells were restored by incuba-
tion in normal growth medium without the PIKfyve inhibitor for 
10 min before being subjected to pull down using GST-Rac1-A15, 
which specifically associates with active GEFs (García-Mata et al., 
2005). Under this condition, the pull-down efficiency of the WT 
of phosphatidylino sitol 3,4,5-trisphosphate, even under normal 
growth conditions, suggesting that the bulk 5-phosphate phospho-
lipid level was suppressed (Supplemental Figure S2). In light of this 
observation, we serum starved NIH-3T3 cells expressing either the 
WT or the phosphomimetic DD mutant of Tiam1 overnight in the 
FIGURE 2: Intramolecular interactions of Tiam1 are reversibly regulated by aPKC phosphorylation. (A) The N-terminal region 
of Tiam1 binds intramolecularly to its PHnCCEx and DHPHc domains. GST-Tiam1-N392 was incubated with the indicated 
MBP-fused Tiam1 fragments (shown schematically in Figure 1A). (B) The PHn and Ex subdomains of PHnCCEx are required 
for binding to the N-terminal region of Tiam1. GST-Tiam1-N392 was incubated with the MBP-fused Tiam1-PHnCCEx 
subdomains PHn, CC, and EX. (C) The N-terminal-most 50 amino acids of Tiam1 are sufficient to bind Tiam1-PHnCCEx. The 
GST-fused N-terminal Tiam1 deletion fragments were incubated with MBP-Tiam1-PHnCCEx. (D) Phosphorylation of the 
N-terminal region of Tiam1 by aPKC abolishes its interaction with the PHnCCEx domain. GST-Tiam1-N392 was incubated 
with GST-aPKCλ-cat in the absence or presence of ATP and subsequently assayed against MBP-Tiam1-PHnCCEx. 
(E) Schematic representations of the “closed” and “open” Tiam1 conformations resulting from the aPKC-regulated 
intramolecular interactions. All experiments shown are representative of at least three independent experiments.
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FIGURE 3: Tiam1 is functionally regulated by intramolecular interactions and aPKC phosphorylation. (A) Constitutive 
aPKC activation enhances the Tiam1-PAR3 interaction. Tiam1 was immunoprecipitated from NIH-3T3 lysates expressing 
WT, constitutively active (CA), or KN mutants of aPKCs, and the immunoprecipitates were immunoblotted with the 
indicated antibodies. (B) Quantification of A. PAR3 coprecipitation was normalized to Tiam1 immunoprecipitation, and 
the fold change relative to the vector control was plotted. (C, D) WT N-terminal region of Tiam1, but not the 
phosphomimetic (DD) N-terminal region of Tiam1, interferes with Tiam1 binding to PAR3. GST-PAR3-4N was incubated 
with MBP-Tiam1-PHnCCEx, and the interaction was titrated by a molar excess of MBP alone, MBP-Tiam1-N/1-WT, or 
MBP-Tiam1-N/1 in which serine residues 29 and 33 were mutated to aspartate (–DD). (C) Representative immunoblot. 
(D) Quantification of C. (E, F) aPKC phosphorylation of Tiam1 primes its activation. WT, the phosphomimetic mutant 
(DD), and the GEF activity-deficient mutant (A1191/1195) of Tiam1 were expressed in NIH-3T3 cells and subjected to 
pull down by GST-Rac1-A15. The lysates were immunoblotted with GFP antibody. The experimental cells were serum 
starved and treated with 100 nM PIKfyve inhibitor for >12 h before normal growth medium was restored for 10 min 
immediately before cell lysis. The control cells were cultured in dimethyl sulfoxide–supplemented normal growth 
medium throughout the duration of the assay. (E) Representative immunoblot. The triplicate samples are numbered. 
(F) Quantification of E. N.D., not detected. All experiments shown are representative of at least three independent 
experiments. Error bars indicate the SEM; *p < 0.05.
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of NIH-3T3 cells induces the membrane translocation of Tiam1 and 
enhances its phosphorylation at threonine residues (Buchanan et al., 
2000). Thus we sought to study the significance of Tiam1-S29 phos-
phorylation in the context of PDGF signaling. When we treated se-
rum-starved NIH-3T3 cells with PDGF, we observed rapid induction 
of Tiam1-S29 phosphorylation, with a peak phosphorylation time 
course of 1 min. This is in contrast to Akt phosphorylation, which 
increased more gradually (Figure 4, A and B). Tiam1-S29 phosphor-
ylation in response to PDGF stimulation was at least partially depen-
dent on aPKCs, since the expression of KN versions of the two iso-
forms reduced phosphorylation levels, whereas pharmacological 
protein was significantly reduced compared with the WT control 
(Figure 3, E and F). However, the phosphomimetic DD mutant was 
pulled down with a similar efficiency as the untreated WT control, 
suggesting that aPKC phosphorylation facilitates Tiam1 activation, 
potentially through mechanisms involving phosphoinositides.
PDGF stimulation induces Tiam1 phosphorylation by aPKC, 
which is mediated by PAR3
Growth factor signaling through RTKs leads to Rac1 activation, cyto-
skeletal remodeling, and cell polarization (reviewed in Burridge and 
Wennerberg, 2004). It was previously shown that PDGF stimulation 
FIGURE 4: aPKC and PAR3 mediate Tiam1-S29 phosphorylation during PDGF signaling. (A, B) PDGF stimulation 
enhances Tiam1-S29 phosphorylation. Serum-starved NIH-3T3 cells were treated with 50 ng/ml PDGF for the indicated 
times, and the lysates were immunoblotted with the indicated antibodies. (C–F) aPKC activity and PAR3 are required for 
PDGF-induced Tiam1-S29 phosphorylation. (C, D) NIH-3T3 cells were transfected with KN mutants of either myc-aPKCλ 
or ζ, serum starved, and treated with PDGF for 5 min. The lysates were immunoblotted with the indicated antibodies. 
(E, F) PAR3 expression was knocked down by siRNA treatment in NIH-3T3 cells before PDGF stimulation, as in C and D. 
At least three independent experiments for each experiment shown. Error bars indicate the SEM; *p < 0.05.
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which enables detection of active Rac1. When Tiam1 expression was 
knocked down by siRNA transfection, PDGF-induced Rac1 activation 
was significantly reduced (Figure 5, A and B). Similar to the results in 
Figure 4, interfering with aPKC activity and PAR3 expression also re-
sulted in suppressed Rac1 activation (Figure 5, C–F).
At the cellular level, growth factor–induced Rac1 activation mani-
fests as cytoskeletal changes, such as peripheral and circular dorsal 
ruffles (Ridley et al., 1992; reviewed in Burridge and Wennerberg, 
2004). We investigated the role of Tiam1 in the PDGF-induced re-
modeling of the actin cytoskeleton in NIH-3T3 fibroblasts by small 
interfering RNA (siRNA)–mediated knockdown. A significant pro-
portion of control siRNA–transfected cells (>50%) formed prominent 
dorsal ruffles 10 min after PDGF treatment, which were largely 
absent when Tiam1 expression was suppressed (Figure 6A and 
inhibition of the conventional PKC isoforms α and β had no effect on 
phosphorylation levels (Figure 4, C and D, and Supplemental Figure 
S3). Of interest, PAR3 was also required for full induction of Tiam1 
phosphorylation (Figure 4, E and F). Because protein phosphoryla-
tion levels are regulated by the balance between the actions of ki-
nases and phosphatases, these results suggest that PDGF stimu-
lates Tiam1-S29 phosphorylation in vivo and that the turnover of this 
phosphorylation is rapid.
Tiam1 phosphorylation by aPKC is required for PDGF-
induced Rac1 activation and dorsal ruffle formation
To establish whether Tiam1 is required for Rac1 activation in response 
to PDGF stimulation, we performed a pull-down assay based on the 
Cdc42/Rac interactive binding (CRIB) motif of the Rac1 effector PAK, 
FIGURE 5: Tiam1, aPKC, and PAR3 are required for the acute PDGF-induced activation of Rac1. (A, B) Tiam1 is required 
for PDGF-induced Rac1 activation. The NIH-3T3 cells were transfected with an siRNA against Tiam1, serum starved, and 
stimulated with PDGF for the indicated times. Activated Rac1 was pulled down by incubating the lysates with the 
GST-fused CRIB region of PAK. The lysates and precipitates were immunoblotted with the indicated antibodies. 
(C–F) aPKC activity and PAR3 are required for the acute activation of Rac1 in response to PDGF treatment. (C, D) The 
NIH-3T3 cells were transfected with KN mutants of either myc-aPKCλ or ζ, serum starved, and treated with PDGF for 
5 min. Activated Rac1 was detected as in A and B. (E, F) PAR3 expression was knocked down by siRNA treatment in 
NIH-3T3 cells before PDGF stimulation as in C and D. Activated Rac1 was detected as in A and B. At least three 
independent experiments for each experiment shown. Error bars indicate the SEM; *p < 0.05.
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(reviewed in Simons and Sampaio, 2011). Therefore we examined 
whether Tiam1 can form a complex with the PDGF receptor. When 
either Tiam1 or PDGFRβ was immunoprecipitated, the opposite 
proteins were reciprocally coprecipitated (Figure 7A). Of note, 
phosphorylated Tiam1 also interacted with PDGFRβ (Figure 7B). 
PAR3 and aPKC were identified not only in the Tiam1 immunopre-
cipitate, as expected, but also in the PDGFRβ immunoprecipitate 
(Figure 7A).
The recovery rate of PAR3 from the PDGFRβ immunoprecipitate 
was consistently higher than that of Tiam1, suggesting that PAR3 
functions as an escort protein linking Tiam1 to PDGFRβ (Figure 7A). 
To validate this interaction, we performed a pull-down assay using 
lysates from COS-7 cells coexpressing GST-fused cytosolic tail (CT) 
of PDGFRβ and myc-tagged FL PAR3 or the relevant vector controls. 
Myc-PAR3-FL was specifically pulled down with GST-PDGFRβ-CT 
(Figure 7C). We also examined whether the two proteins could di-
rectly interact in an in vitro binding assay. The C-terminal coiled-coil 
region of PAR3 (PAR3-4N) was specifically pulled down when the 
indicated PAR3 fragments were passed through columns containing 
GST-PDGFRβ-CT (Supplemental Figure S5, A and B).
Supplemental Figure S4). Of interest, Tiam1 silencing did not ap-
pear to affect the peripheral ruffle formation at later time points 
(Supplemental Figure S4). Similarly, attenuating aPKC activity by ex-
pressing dominant-negative aPKC constructs significantly reduced 
dorsal ruffle formation, as did suppressing PAR3 expression, al-
though to a lesser degree (Figure 6, B and C).
To establish that aPKC mediated PDGF-induced dorsal ruffles 
specifically through Tiam1 phosphorylation, we performed a rescue 
experiment. The expression of WT Tiam1 in NIH-3T3 cells trans-
fected with the Tiam1 siRNA significantly increased the rate of dorsal 
ruffle formation compared with the vector control (Figure 6, D and 
E). Of importance, the expression of the nonphosphorylatable 
Tiam1 mutant failed to restore dorsal ruffle formation (Figure 6, D 
and E). These results suggest that aPKC phosphorylation of Tiam1 
specifically regulates its ability to efficiently activate Rac1 in response 
to PDGF stimulation and that PAR3 also mediates this process.
Tiam1, PAR3, and aPKC interact with PDGF receptor β
Receptor tyrosine kinases and their associated signaling proteins 
are compartmentalized in defined membrane microdomains 
FIGURE 6: Tiam1 phosphorylation by aPKC is required for PDGF-induced dorsal ruffle formation. (A–C) Tiam1, aPKC, 
and PAR3 regulate dorsal ruffle formation in response to PDGF stimulation. The NIH-3T3 cells were transfected with 
(A) the Tiam1 siRNA, (B) myc-aPKCλ or ζ-KN, or (C) the PAR3 siRNA and seeded on poly-d-lysine–coated coverslips. 
The serum-starved cells were stimulated with PDGF for 7 min. Dorsal ruffles were visualized by phalloidin staining and 
quantitated as detailed in Materials and Methods. (D, E) Phosphorylation of Tiam1 at S29 and S33 is required for 
PDGF-induced dorsal ruffle formation. The NIH-3T3 cells were transfected with a Tiam1 siRNA and an siRNA-resistant 
Tiam1-GFP(ΔCMV) (see Materials and Methods), either WT (–WT) or that harboring the nonphosphorylatable alanine 
mutations of serine residues 29 and 33 (–AA). Dorsal ruffle visualization and quantification were performed as in A–C. 
At least three independent experiments for each experiment shown. Scale bar, 20 μm. Error bars indicate the SEM; 
*p < 0.05; N.S., no statistical significance.
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FIGURE 7: PAR3 interacts with PDGFRβ to mediate PDGF signaling to Rac1 through Tiam1. (A) Tiam1, aPKC, PAR3, and 
PDGFRβ form a complex. Tiam1 and PDGFRβ were immunoprecipitated from NIH-3T3 cell lysates. The 
immunoprecipitates were immunoblotted with the antibodies shown. The percentage recovery of each protein is 
indicated to the left. (B) aPKC-phosphorylated Tiam1 can form a complex with activated PDGFRβ. The NIH-3T3 cells 
were serum starved and stimulated with PDGF. The PDGFRβ immunoprecipitates were immunoblotted with the 
Tiam1-pS29 antibody. (C) PAR3 interacts with PDGFRβ. GST or GST-PDGFRβ-CT (cytoplasmic tail; aa 555–1106) and myc 
or myc-PAR3-FL were coexpressed in COS-7 cells. The lysates were pulled down, and the precipitates were probed for 
GST and myc. All experiments shown are representative of at least three independent experiments. (D) PAR3 
constitutively interacts with PDGFRβ. The NIH-3T3 cells were serum starved and treated with PDGF for 5 min. The 
lysates were subjected to immunoprecipitation with the PDGFRβ antibody. The immunoprecipitates were 
immunoblotted with the indicated antibodies. (E) Proposed model for the role of Tiam1 in PDGF-induced Rac1 
activation. PAR3 constitutively interacts with PDGFRβ. In the absence of PDGF stimulation, Tiam1 is not phosphorylated 
at S29 and is biased toward a “closed” conformation, precluding a stable interaction with PAR3. On PDGF stimulation, 
PI3 kinase is recruited to the activated PDGF receptor β. PI3 kinase is important for two reasons. This kinase can 
activate aPKC and stabilize Tiam1 at the plasma membrane through the local formation of its catalytic product 
phosphatidylinositol (3,4,5)-triphosphate (PIP3); it can also indirectly enhance aPKC activity through its substrate, PDK. 
In this way, the population of Tiam1 that is transiently bound to PAR3 is simultaneously phosphorylated by aPKC and 
stabilized at the membrane. Thus phosphorylated Tiam1, no longer conformationally inhibited, can form a stable 
complex with PAR3 at sites of PDGF receptor activation to efficiently activate Rac1 in a localized manner.
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phosphorylation by aPKC can facilitate the restoration of Tiam1 ac-
tivity upon removal of the cellular environment that suppresses Pt-
dIns5P synthesis (Figure 3). Proteins are subject to a complex array 
of posttranslational modifications that regulate their function at mul-
tiple levels. Taken at face value, our results suggest that Tiam1-S29 
phosphorylation and the accompanying structural changes are im-
portant early steps that potentiate the activation of Tiam1 by a di-
rect modulator, such as PtdIns5P.
Our work also expands the role of the PAR complex in RTK sig-
naling by identifying PAR3 as a novel interacting partner of PDGFRβ 
and revealing its role in mediating PDGF signaling to Rac1. Our 
finding that PAR3 directly binds PDGFRβ is one of the first reports 
demonstrating PAR3 interaction with an RTK; PAR3 was recently 
shown to bind DDR1, an atypical RTK, whose substrate is the non-
soluble extracellular matrix protein collagen (Hidalgo-Carcedo 
et al., 2010), and the vascular endothelial growth factor (VEGF) re-
ceptor (Nakayama et al., 2013). The interaction with the VEGF re-
ceptor is notable because the VEGF and PDGF receptor families 
share a single phylogenetic origin (reviewed in Andrae et al., 2008). 
PAR3 contains multiple PDZ domains, and PDGFRβ harbors a PDZ-
binding motif. Although we found that the C-terminal coiled-coil 
region of PAR3 was sufficient to bind to PDGFRβ in vitro, our present 
results do not preclude a PDZ domain–based mode of interaction, 
as proposed for PAR3 and the VEGF receptor (Nakayama et al., 
2013). Additional analyses are in progress to better define the 
mechanisms regulating this interaction.
Tiam1 is also phosphorylated at Ser-29 by hepatocyte growth 
factor (HGF) stimulation in epithelial Madin–Darby canine kidney II 
cells (Supplemental Figure S7A) and in NIH-3T3 cells upon adhesion 
to the extracellular matrix protein fibronectin (Supplemental Figure 
S7B). The PAR complex and Tiam1 were previously implicated in 
HGF-dependent polarized migration (Pegtel et al., 2007) and adhe-
sion-induced cell migration (Wang et al., 2012). Taken together, 
these results raise the possibility that the PAR complex and Tiam1 
constitute a conserved signaling unit that functions in various signal-
ing pathways in a cell context–dependent manner. Although it is 
beyond the scope of the present study, this possibility merits further 
investigation.
MATERIALS AND METHODS
Reagents and chemicals
The following commercial antibodies were used: anti-Tiam1 (C-16) 
and anti-aPKCζ (H-1; Santa Cruz Biotechnology, Santa Cruz, CA); 
anti-PAR3 and anti-Rac1 (EMD Millipore, Darmstadt, Germany); anti-
aPKCλ and anti–transferrin receptor (BD Biosciences, San Jose, CA); 
anti-p85, anti-Erk1/2, anti-Erk1/2-pT202/pY204, anti-Akt, anti-Akt-
pS473, and anti–α-tubulin (Cell Signaling Technology, Danvers, 
MA); and anti-GFP and anti-GST (Sigma-Aldrich, St. Louis, MO). 
Anti-Myc (9E10) and anti-HA (12CA5) antibodies were purified in-
house from hybridoma. Anti-MBP rabbit polyclonal antibody was 
raised against recombinant MBP. Anti–Tiam1-pS29 polyclonal anti-
body was raised against the phosphopeptide (HTSRS(-P)LRLSH; 
MBL, Nagoya, Japan) and was affinity purified using the phospho-
peptide. The following siRNAs from Sigma-Aldrich were used: con-
trol scramble, 5′-CAGUCGCGUUUGCGACUGG-3′; siTiam1#1, 
5′-GACAUUUGGGUCCAUGAAU-3′; siTiam1#2, 5′-CCGAAAUG-
GUGGAGUUUCA-3′; and siPAR3#6, 5′-GGCAUGGAGACCUUG-
GAAG-3′. GST-aPKCλ-cat was expressed in Sf9 cells using a baculo-
virus system and purified using glutathione–Sepharose beads 
(Amano et al., 1999). The aPKC pseudosubstrate inhibitor and the 
PIKfyve inhibitor YM201636 were purchased from EMD Millipore. 
Other chemicals were obtained from commercial sources.
Interactions between adaptor proteins and RTKs are often activ-
ity dependent, with the receptor autophosphorylation sites acting 
as docking sites (reviewed in Wagner et al., 2013). We tested the 
effect of PDGFRβ activity on its interaction with PAR3 by immuno-
precipitating PDGFRβ from serum-starved and PDGF-stimulated 
NIH-3T3 cells. As expected, the p85 regulatory subunit of phos-
phoinositide 3-kinase (PI3 kinase) coprecipitated with PDGFRβ only 
in stimulated cells (Figure 7D, middle). However, PAR3 was compa-
rably coprecipitated with PDGFRβ in both serum-starved and PDGF-
treated cells (Figure 7D, top). Taken together, these results suggest 
that PAR3 constitutively interacts with PDGFRβ to mediate Tiam1 
localization.
DISCUSSION
The present work demonstrates that internal interactions are impor-
tant regulators of Tiam1 function and further clarifies the functional 
interaction between Tiam1 and the PAR complex. The N-terminal 
region of Tiam1 is not organized in any known coherent domain 
structure, and the understanding regarding its function is limited. 
Tiam1 contains a consensus N-terminal myristoylation motif, sug-
gesting that it is constitutively bound to the plasma membrane 
through this irreversible modification. Our fractionation analysis 
shows that WT Tiam1 is predominantly membrane bound, whereas 
the majority of myristoylation-deficient mutant is cytosolic (Supple-
mental Figure S6, A and B). Thus addition of the myristoyl moiety 
appears to be an important means of targeting Tiam1 to the plasma 
membrane. The N-terminal region of Tiam1 also contains tandem 
PEST sequences, which serve as signals for protein degradation 
(Rogers et al., 1986); this is one reason that this region is traditionally 
considered inhibitory. Recently, phosphorylation of Ser-60, immedi-
ately downstream of the PEST sequences, and 14-3-3 binding to 
this motif were shown to be required for Tiam1 degradation, sug-
gesting that destabilization might indeed play a regulatory role 
(Woodcock et al., 2009).
Proteins fluctuate under equilibrium conditions, and the range of 
conformations explored by these fluctuations includes both permis-
sive/active and inhibitory/inactive structures. Moreover, protein con-
formations can be stably biased by posttranslational modifications 
in response to external cues (reviewed in Gibbs, 2014). This has 
been elegantly characterized in Vav proteins, a Dbl-family GEF like 
Tiam1 (Aghazadeh et al., 2000; Zugaza et al., 2002; Yu et al., 2010; 
reviewed in Bustelo, 2014). Our binding studies show that at the 
extremes, Tiam1 exists in a “closed” conformation, where the N-
terminal region masks other functionally significant regions within 
the Tiam1 protein, namely, PHnCCEx and PHc, and an “open” con-
formation. In addition, the bias toward the “open” conformation is 
conferred by phosphorylation at Ser-29 (Figure 2). These intramo-
lecular interactions could serve an inhibitory function superseding or 
complementary to the previously reported destabilization effect. 
The interaction with the PHnCCex domain ostensibly suppresses 
the protein–protein interactions and concomitant localization; our 
immunoprecipitation and in vitro titration experiments with PAR3 
clearly illustrate this effect by showing that the interaction is stabi-
lized in the presence of a permissive signal, that is, Tiam1-Ser-29 
phosphorylation (Figure 3).
Similarly, we demonstrate a modulatory role for the N-terminal-
PHc interaction in regulating Tiam1 GEF activity. Viaud et al. (2014) 
recently showed that binding of the lipid messenger PtdIns5P to 
Tiam1-PHc was required for its activation. Thus our experimental 
conditions were aimed at elucidating whether aPKC phosphoryla-
tion of Tiam1 plays a role in its activation when controlled for access 
to PtdIns5P. In this context, our assay for active GEF showed that 
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(50 mM Tris-HCl, pH 7.5, 500 mM NaCl, 1 mM MgCl2, 1 mM ethyl-
ene glycol tetraacetic acid [EGTA], 0.5% NP-40, and protease and 
phosphatase inhibitors) containing 20 μg of GST-PAK-CRIB per sam-
ple. After removal of the debris by centrifugation, the lysates were 
and incubated with glutathione–Sepharose for 30 min. The beads 
were washed with buffer B and dissolved in SDS sample buffer. Ali-
quots of the lysate and eluate were immunoblotted with an anti-
Rac1 antibody to monitor the total and GTP-bound activated Rac1, 
respectively.
Affinity precipitation of the active GEFs was performed as previ-
ously described (García-Mata et al., 2005). Cell lysates were pre-
pared in buffer C (20 mM 4-(2-hydroxyethyl)-1-piperazineethanesul-
fonic acid [HEPES]–NaOH, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1 
mM DTT, 1% Triton X-100, and protease and phosphatase inhibi-
tors) and incubated with 100 μg of purified GST-Rac1-A15 bound to 
glutathione–Sepharose overnight in the cold with end-over-end agi-
tation. The beads were then washed with buffer C and dissolved in 
SDS sample buffer.
Immunoprecipitation assay
Immunoprecipitation was performed essentially as described previ-
ously (Kallin et al., 2004). Cells were washed with ice-cold PBS and 
lysed in IP buffer (20 mM HEPES-NaOH, pH 7.4, 100 mM NaCl, 5 
mM EDTA, 10% glycerol, 1% Triton X-100, and protease and phos-
phatase inhibitors). After removal of the debris by centrifugation, 
the lysates were incubated with antibodies (8 μg) overnight in the 
cold with end-over-end mixing. Protein A–Sepharose (GE Health-
care Life Sciences) was added to the lysates, and incubation was 
extended for 2 h. The beads were washed with IP buffer and dis-
solved in SDS sample buffer.
In vitro phosphorylation assay
The kinase reaction was conducted in 50 μl of kinase buffer (20 mM 
Tris-HCl, pH 7.5, 5 mM MgCl2, 1 mM EGTA, and 1 mM DTT) con-
taining 100 μM [γ-32P]ATP, 0.1 μM recombinant kinase (GST-aPKCλ-
cat), and 1 μM substrate (purified GST-fusion proteins). After incuba-
tion for 0.5 h at 30°C, the reaction mixtures were boiled in SDS 
sample buffer and subjected to SDS–PAGE and silver staining. The 
radiolabeled bands were visualized with an image analyzer (Ty-
phoon FLA 9000; GE Healthcare Life Sciences).
Subcellular fractionation
Subcellular fractionation was performed essentially as described in 
Takano et al. (2010). The transfected cells were collected in fraction-
ation buffer (20 mM HEPES-NaOH, pH 7.4, 100 mM NaCl, 2 mM 
MgCl2, 1 mM EDTA, and protease and phosphatase inhibitors) and 
lysed by sonication. After centrifugation at 2500 × g for 5 min at 4°C, 
the supernatant was fractionated into soluble and particulate frac-
tions by centrifugation at 100,000 × g for 1 h at 4°C.
Immunohistochemical analysis
The cells were fixed with 3.7% Formalin for 15 min, followed by 
permeabilization with 0.25% Triton X-100 for 5 min. After incubation 
with blocking buffer (1 mg/ml bovine serum albumin, PBS) for 60 
min at room temperature, the cells were incubated with the indi-
cated primary antibodies overnight at 4°C and then incubated with 
the indicated secondary antibodies for 1 h at room temperature. 
The cells were observed under a confocal laser microscope (LSM5 
PASCAL; Carl Zeiss, Jena, Germany) using a 1.4 numerical aperture 
(NA) CFI Plan-Apochromat 63× oil immersion objective lens or un-
der an inverted microscope (IX-71; Olympus, Tokyo, Japan) using a 
0.4 NA LCPlanFI 20× lens.
Plasmid constructs
We subcloned cDNA fragments of mouse Tiam1, mouse Tiam2/
STEF, rat PAR3, mouse aPKCλ, human aPKCζ, mouse Rac1, and hu-
man PDGFRβ into pGEX (GE Healthcare Life Sciences, Marlbor-
ough, MA), pMAL (New England BioLabs, Ipswich, MA), pEGFP 
(Takara Bio, Otsu, Japan), pCAGGS-myc, and pMT2SM-HA. For the 
rescue and fractionation experiments, a modified pEGFP vector 
with a 5′ deletion of the cytomegalovirus promoter (ΔCMV) was pre-
pared in the manner described by Slater et al. (2008) to reduce the 
expression levels. The cDNAs encoding Tiam1, Tiam2/STEF, PAR3, 
aPKCλ, aPKCζ, and Rac1 were obtained as described previously 
(Nishimura et al., 2005; Wang et al., 2012; Matsui et al., 2015). The 
PDGFRβ cDNA was obtained from DNAFORM (Yokohama, Japan). 
For the rescue experiments, we used siRNA-insensitive Tiam1 mu-
tant generated with a site-directed mutagenesis kit (Agilent Tech-
nologies, Santa Clara, CA) by introducing silent mutations within the 
siRNA target sequence. The Tiam1 alanine and aspartate mutations, 
as well as the Rac1 alanine mutation, were generated in the same 
way. The siRNA-insensitive PAR3 and the various fragments of PAR3, 
Tiam1, and Tiam2/STEF were described previously (Nishimura et al., 
2005; Wang et al., 2012).
Cell culture and transfection
COS-7 cells were cultured in DMEM with 10% fetal bovine serum, 
and NIH-3T3 cells were maintained in DMEM with 10% calf serum. 
The COS-7 cells were transfected with Lipofectamine LTX (Thermo 
Fisher Scientific, Waltham, MA) according to the manufacturer's pro-
tocol, and the NIH-3T3 cells were transfected using the Neon Trans-
fection System (Thermo Fisher Scientific) according to the manufac-
turer's protocol. Lipofectamine RNAiMAX (Thermo Fisher Scientific) 
was used for the siRNA transfections.
Protein purification
Recombinant proteins were produced in Escherichia coli (XL-1 Blue, 
BL21DE3, or RosettaDE3) and purified as described previously 
(Wang et al., 2012). Briefly, the collected bacteria were suspended 
and sonicated. After ultracentrifugation for 1 h at 100,000 × g, the 
supernatants were applied to columns containing glutathione–Sep-
harose (GE Healthcare Life Sciences) for the GST-fusion proteins or 
amylose resin (New England BioLabs) for the MBP-fusion proteins. 
After the columns were washed, the proteins were eluted with buffer 
containing reduced glutathione (for GST-fused proteins) or maltose 
(for MBP-fused proteins) and then dialyzed against the appropriate 
buffer. All protein purification procedures were performed at 4°C. 
Preparation of the GST-Rac1-A15 affinity beads was carried out as 
previously described (García-Mata et al., 2005).
In vitro binding assay
Purified MBP-fusion proteins (50 pmol) were incubated with affinity 
beads coated with GST-tagged proteins (10 pmol) in buffer A (20 
mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, 1 mM dithiothrei-
tol [DTT], 0.1% 3-[(3-cholamidopropyl)dimethylammonio]-1-pro-
panesulfonate, 0.1% Triton X-100, and protease inhibitors). The 
beads were then washed with buffer A, and the bound proteins 
were eluted with buffer A containing 10 mM reduced glutathione. 
The eluates were subjected to SDS–PAGE, followed by immunoblot 
analysis using an anti-MBP antibody.
Rac1 and GEF activity assays
Rac1 activity was analyzed using GST-PAK-CRIB pull downs, as pre-
viously described (Wang et al., 2012). The cells were washed with 
ice-cold phosphate-buffered saline (PBS) and lysed with buffer B 
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For the quantitative analysis of dorsal ruffle formation, PDGF-
treated cells were stained for F-actin with phalloidin. Sequential mi-
crographs covering the entire coverslip for the relevant conditions 
were obtained. The dorsal ruffles were systematically extracted from 
the binarized images by defining them as intracellular ringed struc-
tures with a circularity index value >0.7; a circularity value of 1 cor-
responds to a perfect circle, where circularity = 4π(area/perimeter2). 
Dorsal ruffle formation was quantified as the proportion of cells that 
formed dorsal ruffles within the relevant cell populations. The im-
ages were processed using plug-ins bundled with the Fiji iteration of 
ImageJ (Schindelin et al., 2012).
Statistical analysis
Student's t test and analysis of variance (ANOVA) were performed 
after the data were confirmed to fulfill the criteria of normal distribu-
tion and equal variance. If the overall ANOVA was significant, we 
performed a post hoc test. Tukey's honest significant difference mul-
tiple range test was performed. Statistical analyses were performed 
with GraphPad Prism, version 5.0 (GraphPad Software, La Jolla, CA). 
p <0.05 was considered to indicate statistical significance.
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